Aleks Engel


Aleks joined Novo Holdings A/S in September 2014 as Asset Director in Novo Large Investments taking part in managing and developing the growing portfolio of investments.

Prior to joining Novo Holdings, Aleks was employed as Vice President in Baxter International in Illinois and Shanghai, working with global M&A licensing, growth strategies, investment prioritization and go-to-market planning. Other previous employments include Pfizer Global Research and Development, Thomson Scientific & Healthcare and McKinsey & Company (all U.S.A.).

Aleks holds a Ph.D. in Biochemical Engineering (1999) and a M.Sc. in Chemical Engineering Practice (1995) from Massachusetts Institute of Technology.